The natural history of human immunodeficiency virus infection among adults in Mumbai

National Medical Journal of India

Volumn 16, Issue 3, 2003, Pages 126-131

  Hira, Subhash K ^a   Shroff, H J ^a   Lanjewar, D N ^b   Dholkia, Y N ^a   Bhatia, Vandana P ^a   Dupont, H L ^c  

^a SIR J J GROUP OF HOSPITALS   (India)

^b GMC and Sir JJ group of Hospitals   (India)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE CONTROL STUDY; CHRONIC DIARRHEA; CHRONIC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; COUGHING; DISEASE ACTIVITY; DISEASE COURSE; EUROPE; FEMALE; FEVER; FOLLOW UP; HEMOPHILIA; HERPES ZOSTER; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INDIA; LONGITUDINAL STUDY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PREVALENCE; STAGING; STATISTICAL ANALYSIS; SURVIVAL TIME; SYMPTOMATOLOGY; THRUSH; TIME SERIES ANALYSIS; TUBERCULOSIS; UNITED STATES; WEIGHT REDUCTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS;

EID: 0042133156     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jaffe HW, Darrow WW, Echenberg DF, O'Malley PM, Getchell JP, Kalyanaraman VS, et al. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow up study. Ann Intern Med 1985;103:210-14.
2. Lefrere JJ, Lambin P, Courouce AM, Doinel C. Progression to AIDS in the majority of asymptomatic HIV-infected people. AIDS 1989;3:603-4.
3. Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristera R, Ortona L, et al. The natural history of HIV infection in intravenous drug users: Risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
4. Royce RA, Luckmann RS, Fusaro RE, Winkelstein W Jr. The natural history of HIV-1 infection: Staging classifications of disease. AIDS 1991;5:355-64.
5. Simmonds P, Beatson D, Cuthbert RJ, Watson H, Reynolds B, Peutherer JF, et al. Determinants of HIV disease progression: Six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 1991;338:1159-63.
6. Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61-6.
7. Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, Schellekens PT, et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989;1:983-5.
8. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein WW Jr, et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994;140:747-58.
9. Rezza G. Determinants of progression to AIDS in HIV infected individuals: An update from the Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17(Suppl 1):S13-S16.
10. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272: 1167-70.
11. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-42.
12. de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
13. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. Lancet 2002;359:2059-64.
14. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997;350:245-50.
15. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: Is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002;16:597-603.
16. Morgan D, Mahe C, Mayanja B, Whitworth JA. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: Prospective cohort study. BMJ 2002;324:193-6.
17. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr. HIV infection in Haiti: Natural history and disease progression. AIDS 2000;14:2515-21.
18. Hira SK, Dupont HL, Lanjewar DN, Dholkia YN. Severe weight loss: The predominant clinical presentation of tuberculosis in patients with HIV infection in India. Natl Med J India 1998;11:256-8.
19. Clinical case definition. In: Clinical management of HIV and AIDS at district level. New Delhi: WHO Regional office for Sauth-East Asia, 1996(SEA/AIDS/101).
20. Kura MM, Hira SK, Kohli M, Dalal PJ, Ramnani VK, Jagtap MR. High occurrence of HBV among STD clinic attenders in Bombay, India. Int J STD AIDS 1998;9: 231-3.
21. Hira SK. Developing an appropriate HIV classification for Asia and the Pacific. JAMA 1998;14(Suppl):60-2.
22. Mathematica 4, Wolfram Research, 1999.
23. Epi-Info 2000 Version 1.1.2, Centers for Disease Control, Atlanta, released 2001.
24. Medley GF, Anderson RM, Cox DR, Billard L. Incubation period of AIDS in patients infected via blood transfusion. Nature 1987;328:719-21.
25. Lui KJ, Darrow WW, Rutherford GW 3rd. A model-based estimate of the mean incubation period for AIDS in homosexual men. Science 1988;240:1333-5.
26. Darby SC, Rizza CR, Doll R, Spooner RJ, Stratton IM, Thakrar B. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: Report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ 1989;298:1064-8.
27. Barchielli A, Acciai S, Lazzeri V, Buiatti E. Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992. Eur J Epidemiol 1997;13:125-32.
28. Lemp GF, Payne SF, Rutherford GW, Hessol NA, Winkelstein W Jr, Wiley JA, et al. Projections of AIDS morbidity and mortality in San Francisco. JAMA 1990;263: 1497-501.
29. Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 1989;321:947-52.
30. Chang HG, Morse DL, Noonan C, Coles B, Mikl J, Rosen A, et al. Survival and mortality pattern of an acquired immunodeficiency syndrome (AIDS) cohort in New York State. Am J Epidemiol 1993;131:341-9.
31. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: An 11 year follow-up study. BMJ 1990;301:1183-8.
32. Carre N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS 1994;8:797-802.
33. Vial PA, Ferreccio C, Abarca K, Ortiz E, Noriega M, Perez C, et al. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients. J Rev Med Chil 1996;124:525-35. [Article in Spanish]
34. Perneger TV, Sudre P, Lundgren JD, Hirschel B. Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group. BMJ 1995;311:1468-71.
35. Guimaraes MD. Temporal study of AIDS-associated diseases in Brazil, 1980-1999. Cad Saude Publica 2000;16 (Suppl 1):21-36.
36. Wolff M, Bustamante C, Bidart T, Dabanch J, Diomedi A, Northland R. [Impact of antiretroviral therapy in mortality of Chilean HIV (+) patients: A case-control study.] Rev Med Chile 2000;128:839-45. [Article in Spanish]
37. Arici C, Ripamonti D, Ravasio V, Maggiolo F, Rizzi M, Finazzi MG, et al. Long-term clinical benefit after highly active anti-retroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution. Int J STD AIDS 2001;12: 573-81.
38. Maggi P, Larocca AM, Quarto M, Serio, G, Brandonisio O, Angarano G, et al. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2000;17.